STOCK TITAN

NUTRA PHARMA CORP (NPHC) Revenue by Year

NPHC

NUTRA PHARMA CORP generated $258K in revenue in fiscal year 2025. This represents an increase of 4.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $161K in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters NUTRA PHARMA CORP has filed alongside them.

FY2025 annual
Revenue $258K
YoY +4.6%
5Y CAGR +37.8%
10Y CAGR -1.2%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NPHC Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$161K$258K+4.6%$246K+19.8%$206K+41.0%$146K+49.2%$98K+88.3%$52K-50.3%$104K-20.1%$131K+7.9%$121K-28.1%$168K-42.2%$291K-51.0%$595K+467.1%$105K-48.4%$203K+27.4%$160K

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

NPHC Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$34K-59.2%$27K-63.2%$29K-64.7%$70K-6.3%$85K+63.5%$74K+96.1%$82K+74.1%$75K+45.3%$52K-1.3%$38K-30.8%$47K-40.5%$52K+109.6%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More NUTRA PHARMA CORP financials

Frequently Asked Questions

What was NUTRA PHARMA CORP's revenue in fiscal year 2025?

NUTRA PHARMA CORP generated $258K in revenue in fiscal year 2025.

How fast is NUTRA PHARMA CORP's revenue growing?

NUTRA PHARMA CORP (NPHC) revenue rose by 4.6% year over year, from $246K to $258K in fiscal year 2025.

What is NUTRA PHARMA CORP's revenue over the last twelve months?

NUTRA PHARMA CORP (NPHC) reported $161K in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, NUTRA PHARMA CORP (NPHC) revenue went from $160K in fiscal year 2011 to $258K in fiscal year 2025.

NUTRA PHARMA CORP (NPHC) reported $34K in revenue in Q2 2026. This represents a decrease of 59.2% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what NUTRA PHARMA CORP (NPHC) reported on that line in every period on record.